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Activation of the innate immune system by bacterial DNA and DNA of other invertebrates represents a
pathogen recognition mechanism. In this study we investigated macrophage responses to DNA from the
intestinal protozoan parasite Entamoeba histolytica. E. histolytica genomic DNA was purified from log-phase
trophozoites and tested with the mouse macrophage cell line RAW 264.7. RAW cells treated with E. histolytica
DNA demonstrated an increase in levels of tumor necrosis factor alpha (TNF-) mRNA and protein produc-
tion. TNF- production was blocked by pretreatment with chloroquine or monensin. In fact, an NF-B
luciferase reporter assay in HEK cells transfected with human TLR9 demonstrated that E. histolytica DNA
signaled through Toll-like receptor 9 (TLR9) in a manner similar to that seen with CpG-ODN. Immunoflu-
orescence assays confirmed NF-B activation in RAW cells, as seen by nuclear translocation of the p65 subunit.
Western blot analysis demonstrated mitogen-activated protein kinase activation by E. histolytica DNA. E.
histolytica DNA effects were abolished in MYD88/ mouse-derived macrophages. In the context of disease,
immunization with E. histolytica DNA protected gerbils from an E. histolytica challenge infection. Taken
together, these results demonstrate that E. histolytica DNA is recognized by TLR9 to activate macrophages and
may provide an innate defense mechanism characterized by the induction of the inflammatory mediator
TNF-.
The vertebrate immune system has evolved to recognize
pathogen-associated molecular patterns (PAMP) in order to
counteract bacterial, viral, and parasitic infections (18). The
Toll-like receptor (TLR) family of proteins specifically recog-
nizes these PAMPs and activates antipathogen responses char-
acterized by Th1 cytokines (1). The role of TLRs is to discrim-
inate self from “non-self” molecules, such as unmethylated
CpG DNA. Mammalian DNA is highly methylated at the CG
dinucleotide whereas bacterial DNA and DNA of other inver-
tebrates is not, and this feature is key to its immunostimulatory
activity (27, 40). CpG DNA must first be endocytosed, and
upon endosomal acidification it is specifically engaged by TLR
9 (TLR9) (17, 28). The activated receptor initiates a signaling
cascade, starting with the recruitment of MYD88, IRAK, and
TRAF6, which ultimately leads to the downstream activation
of MAPK and NF-B (10, 24). CpG DNA demonstrates mi-
togenic activity with respect to B cells (16, 27) and activates
dendritic cells and macrophages to produce proinflammatory
cytokines such as tumor necrosis factor alpha (TNF-), inter-
leukin-1 (IL-1), and IL-6 (25, 26).
The intestinal protozoan parasite Entamoeba histolytica is
the etiological agent of amebiasis in humans. Although ame-
biasis remains a prevalent disease in developing countries, only
10 to 14% of infected individuals progress to invasive amebi-
asis characterized by amebic colitis. The pathological events or
immune events leading to amebic invasion are still unknown;
however, recent epidemiological studies revealed acquired re-
sistance and inherited susceptibility to amebiasis (2, 13, 14).
Many studies have also established that cell-mediated or Th1
immunity is of importance in host defense against amebiasis.
Lymphocytes from individuals who have recovered from inva-
sive amebiasis display amebicidal activity and secrete high
amounts of IL-2 and gamma interferon (IFN-) (33, 34). Other
cells demonstrate amebicidal activity such as activated neutro-
phils and macrophages (35–37), and TNF- as well as nitric
oxide has a crucial role in initiating this effect.
Th1 polarization in response to amebic infection could be
due to innate activation of TLR. It is obvious that NF-B must
be involved in the observed inflammation response, which can
lead to tissue damage; however, it may also be required for
disease resolution. It has been shown that inhibition of NF-B
blocks the inflammatory response to ameba in human intesti-
nal xenograft models (38), whereas patients given corticoste-
roids have increased disease severity (21). Several parasite
molecules could be involved in early immune activation events.
E. histolytica lipopeptidophosphoglycan has been shown to
signal through TLR2 and TLR4, inducing Th1 cytokines in
monocytes (30). The parasite cell surface lectin galactose–N-
acetyl-D-galactosamine-inhibitable lectin (Gal-lectin) is well
characterized and known to induce direct dendritic cell and
macrophage activation (19, 35, 36). The role of other parasite
molecules in innate immunity and Th1 polarization remains
unclear. Given the immunogenicity of foreign DNA and its
role in Th1 induction via TLR9, there is a potential role for E.
histolytica DNA in the activation of innate immunity.
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In this study, we determined whether E. histolytica DNA
could activate naive murine macrophages. Herein we dem-
onstrate that E. histolytica DNA activates macrophages to
produce TNF- and that this activation is mediated through
TLR9. Blocking endosomal maturation greatly reduced
TNF- expression; furthermore, this expression was lost in
MYD88/ bone marrow-derived macrophages. Repeated
injection of E. histolytica DNA in gerbils conferred protec-
tion from amebic challenge infection and was characterized
by IFN- expression. Thus, we identified another parasite
molecule capable of activating an innate immune response
which may contribute to host defense against amebiasis.
MATERIALS AND METHODS
Reagents and parasites. E. histolytica strain HM1:IMSS trophozoites were
grown in axenic culture in TYI-S-33 medium (20). Parasites were grown for 72 h
(log phase) for use in all experiments. The native Gal-lectin was purified from
amebae on an immunoaffinity column as previously described (32). E. histolytica
DNA was extracted from trophozoites as previously described (3). Briefly, the
parasite pellet was frozen in liquid nitrogen and ground to a fine powder with
mortar and pestle. The pellet was resuspended in lysis buffer containing 1 mg/ml
proteinase K (Invitrogen) and incubated for 30 min at 65°C. The lysate was
subjected to a series of phenol:chloroform extractions, and DNA was precipi-
tated with ethanol. DNA was treated with RNase A (Qiagen) for 30 min at 37°C
before use in experiments. Lipopolysaccharide (LPS) (Escherichia coli serotype
0111:B4; Sigma-Aldrich, St. Louis, MO) was used at 100 ng/ml or 1 g/ml as
indicated. CpG-ODN 10103 (TCG TCG TTT CGT CGT TTT GTC GTT) with
a full phosphorothioate backbone was purchased from Coley Pharmaceutical
Group (Kanata, Canada) and used at 2 M. Calf thymus DNA (Sigma) was used
as a negative control at 30 g/ml. Salmonella genomic DNA was purified as
previously described (31) and used as a positive control at 30 g/ml. Chloroquine
and monensin (Sigma) were used for blocking experiments, and DNase I (Qia-
gen) was used to digest DNA overnight. Polymyxin B sulfate was purchased from
Sigma.
Cell culture. The mouse macrophage cell line RAW 264.7 and HEK 293 cells
were cultivated in Dulbecco’s modified Eagle’s medium (Invitrogen) supple-
mented with 10% fetal bovine serum, 10 mM HEPES, and 5 mg/ml penicillin-
streptomycin. Cells from the L929 mouse fibroblast cell line were cultivated in
minimal essential medium (Invitrogen) supplemented as described above. Bone
marrow-derived macrophages were propagated from wild-type (C57BL/6) or
MYD88/ mice as previously described (19). Briefly, femurs and tibias were
removed, and the bone marrow was flushed using a 27-gauge syringe. Red blood
cells were lysed with red blood cell lysing buffer (Sigma) and washed three times
in RPMI 1640 medium (Invitrogen). Cells were cultured in six-well plates (2.5 
105 cells/ml) in RPMI 1640 media supplemented with 5% fetal bovine serum, 10
mM HEPES, 50 M 2-mercaptoethanol, 2 mM glutamine, 5 mg/ml penicillin-
streptomycin sulfate and 10 ng/ml recombinant moose GM-CSF (R&D Systems,
Minneapolis, MN). Nonadherent cells were removed after 5 days, and remaining
cells were cultured another 48 h and then subcultured into new plates to enrich
the macrophage population.
Real-time PCR. RAW cells or bone marrow-derived macrophages were stim-
ulated with the indicated antigens or media alone for 3 h. Total mRNA was
extracted using Trizol (Invitrogen) following the manufacturer’s instructions.
DNase-treated total mRNA (1 to 2 g) was reverse transcribed with Moloney
murine leukemia virus enzyme and random hexamer primers (Invitrogen). Real-
time PCR analysis using SYBR green (Qiagen) and mouse-specific primers (9)
was used to determine relative cytokine gene expression levels. Cytokine gene
expression levels are represented as severalfold increases over RPMI-stimulated
control results corrected for the presence of the GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) housekeeping gene as determined by the 2ct
method (9). Real-time DNA amplification assays were conducted in triplicate
using a Rotor-Gene 3000 system (Corbett Research). For gerbil cytokine expres-
sion determinations, spleen cells were stimulated in vitro for 18 h and mRNA
was extracted and cDNA prepared as described above. Real-time PCR was
performed as described above but with gerbil-specific Taqman probes (20).
TNF- bioassay and Western blot analysis. The L929 mouse fibroblast cell
line was used in a TNF- bioassay with treated RAW cell supernatants. L929
cells were trypsinized and resuspended at a cell density of 3.5  105 cell/ml. A
100-l cell suspension was added to each well in a 96-well plate, and cells were
grown overnight. The following day the media was removed and replaced with
minimal essential medium containing 50 g/ml cycloheximide and either TNF-
standards or 24-h-stimulated RAW cell supernatants. Plates were incubated for
18 h at 37°C and then analyzed for cell viability with crystal violet stain. Cell
supernatants were also concentrated and separated by 12% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis. Proteins were transferred to nitrocel-
lulose and probed for TNF- protein (Santa Cruz).
Griess reaction. NO production in RAW cell culture supernatants (96 h
stimulation) was measured as nitrite accumulation in a Griess reaction assay.
Cell supernatants (50 l/well) were transferred to a 96-well plate and mixed with
equal volumes of 0.1% N-(1-naphtyl)-ethylenediamine dihydrochloride (Sigma)
and 1% sulfanilamide (Sigma) in 2.5% H3PO4. Absorbance was read at 540 nm
and compared to a sodium nitrite (NaNO2) standard curve.
Mitogen-activated protein kinase (MAPK) Western blotting. RAW cells were
stimulated with the indicated antigens for 30 min. The cells were washed, and
the cell pellet was collected. Cytoplasmic extracts were prepared with NE-
PER nuclear and cytoplasmic extraction reagents (Pierce) following the man-
ufacturer’s instructions. Cytoplasmic proteins (30 g) were resolved by 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred
onto a nitrocellulose membrane. The membrane was blocked with a 5% milk
solution, washed with Tween–Tris-buffered saline, and incubated with pri-
mary antibody against phosphorylated p38, Jun N-terminal protein kinase
(JNK), and extracellular signal-regulated kinase (ERK) (Santa Cruz). Bound
antibody was visualized using secondary horseradish peroxidase-conjugated
antibody and enhanced chemiluminescence (ECL Plus reagent; Amersham).
Immunofluorescence. RAW cells (1.5  106 cell/ml) were grown on glass
coverslips overnight for use in an immunofluorescence assay. The following day,
cells were washed and treated with LPS (1 g/ml), E. histolytica DNA (30 g/ml),
or control DNA (30 g/ml) for 45 min at 37°C. After incubation, cells were
washed and fixed with 100% methanol at 20°C for 5 min. Cells were washed
again and permeabilized with 2% Igepal (Sigma) for 5 min at room temperature.
Cells were washed again and then blocked with 1% bovine serum albumin–
phosphate-buffered saline (bovine serum albumin-PBS) for 30 min at room
temperature and washed thoroughly. To visualize NF-B translocation, cells
were stained with p65 antibody (Santa Cruz 8008) diluted 1:200 in PBS–0.1%
bovine serum albumin for 1 h at room temperature in a humidified chamber.
Cells were washed and stained with anti-mouse fluorescein isothiocyanate-con-
jugated secondary antibody (Chemicon) for 30 min as described above. After
incubation the cells were washed and mounted with VectaShield onto glass
slides. Slides were visualized using a Nikon Eclipse E400 fluorescence micro-
scope.
Transient transfection and reporter assay. HEK 293 cells were seeded at 6.0 
105 cell/well and transfected overnight in six-well plates by a CaCl2 precipitation
method with 1 g pNFKB-Luc (Stratagene) and 1 g pcDNA human TLR9 or
control plasmid. After overnight culture growth the transfection medium was
removed and cells were stimulated with various stimuli for 12 h. Cell lysates were
assayed for luciferase activity by use of a luciferase report assay system (Pro-
mega). Luciferase activity was measured with a luminometer (Victor II; Wallac)
and was normalized to control transfection results and is expressed as severalfold
increases over matched control results.
Animal immunizations. Male gerbils (Meriones unguiculatus) (Charles River,
St. Constant, Canada) (six to nine weeks old) were injected intramuscularly in
the hind legs with 50 g E. histolytica DNA only, 10 g of Gal-lectin and 50 g
E. histolytica DNA, or 10 g Gal-lectin only in 100 l PBS. Gerbils received
identical booster injections at 7 and 14 days after the initial injection. At day 20,
gerbils were anesthetized and challenged via intrahepatic injection of 106 E.
histolytica amebae (HM1:IMSS) into the left liver lobe as previously described
(6). Gerbils were sacrificed at 10 days postchallenge, and spleens and serum
samples were collected. Livers were removed, and amebic liver abscess (ALA)
weight relative to total liver weight was measured. All protocols in this study were
carried out with the approval of the University of Calgary Animal Care Com-
mittee.
Statistical analysis. Differences between experimental groups in the mean
values were compared using Student’s unpaired t test. P values 	 0.05 are
considered significant.
RESULTS
Induction of TNF- by E. histolytica DNA. CpG DNA is
known to induce a range of cytokines in macrophages, includ-
ing IL-12, TNF-, IL-1
, and IL-6 (26). We first evaluated the
ability of E. histolytica DNA to activate macrophages by deter-
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mining TNF- induction. RAW mouse macrophages were
stimulated with increasing amounts of E. histolytica DNA, and
TNF- mRNA expression was measured by real-time PCR. As
shown in Fig. 1A, E. histolytica DNA induces increased TNF-
mRNA expression in a dose-dependent manner. Treatment of
E. histolytica DNA with polymyxin B did not alter the TNF-
response in macrophages, indicating that the activation was not
due to LPS contamination (data not shown). We also com-
pared TNF- induction by E. histolytica DNA to results ob-
tained with CpG-ODN and LPS, both of which represent
PAMPs known to activate macrophages. E. histolytica DNA-
induced TNF- expression was not as high as LPS- and CpG-
ODN-positive control results; however, it was significantly
higher than that seen with the nonstimulatory control GpC-
ODN (Fig. 1B). Additionally, E. histolytica DNA was able to
stimulate Il-1
 and Il-6 mRNA expression (data not shown).
In order to confirm that the observed increase in TNF-
mRNA corresponds to an increase in cytokine release from
macrophages we performed a bioassay with mouse L929 fibro-
blasts which are sensitive to TNF-. RAW cells were treated
for 24 h and cell culture supernatants added to the responder
cells for 18 h. In agreement with the real-time PCR data, LPS
and E. histolytica DNA were both positive (P 	 0.05) for the
production of TNF- protein, as was Salmonella enterica sero-
var Typhimurium DNA (Fig. 2). In contrast, calf thymus DNA
and DNase-treated E. histolytica DNA did not induce signifi-
cant amounts of TNF- secretion. These data implied that
macrophages were activated by E. histolytica DNA and thus we
focused our attention on the characterization of this response.
Effect on nitric oxide production. Activated macrophages
are a source of nitric oxide, which helps generate effective
innate immunity against viruses, bacteria, and parasites. Nitric
oxide is also the main cytotoxic molecule produced by activated
macrophages for cytotoxicity against E. histolytica. We evalu-
ated the effect of various stimuli on macrophage nitric oxide
production. In the experiment shown in Fig. 3 A, we measured
iNOS mRNA expression in control and treated macrophages.
The data show that E. histolytica DNA could increase inducible
nitric oxide synthase (iNOS) mRNA to an extent similar to that
seen with CpG-ODN, while LPS and S. enterica serovar Ty-
phimurium DNA induced higher mRNA expression levels.
Calf thymus DNA, however, could not induce an increase in
iNOS mRNA levels. We used 96-h culture supernatants in a
Griess reaction to indirectly measure nitric oxide production
by stimulated macrophages. E. histolytica DNA was able to
induce nitric oxide production significantly more than control
and calf thymus DNA (P 	 0.05). The amount of NO mea-
sured, however, was less than that seen with LPS, CpG-ODN,
or S. enterica serovar Typhimurium DNA stimulation (Fig.
3B).
Inhibition of acidification. TLR9 is activated intracellularly
by bacterial DNA and CpG-ODNs by translocation from the
endoplasmic reticulum to endosomes containing the CpG
DNA (28). Endosomal acidification and maturation seem to be
required for proper TLR9 signaling. We tested the effects of
chloroquine (5 g/ml) and monensin (20 M), both inhibitors
of endosomal acidification, on macrophage TNF- expression
after exposure to various stimuli. Pretreatment of RAW mac-
rophages with chloroquine or monensin reduced the potency
of both E. histolytica DNA and S. enterica serovar Typhi-
murium DNA (P 	 0.05) but not that of LPS (Fig. 4). In fact,
retained activity with LPS demonstrated specificity for TLR9
FIG. 1. E. histolytica DNA activates macrophage TNF- produc-
tion. (A) Real-time PCR analysis was performed on RAW 264.7 mac-
rophage mRNA collected after 3 h of in vitro incubation with increas-
ing amounts of E. histolytica (E.h) DNA (1 to 25 g/ml). Data are
represented as severalfold increases over medium-only control results
for mRNA expression. (B) TNF- mRNA levels of RAW 264.7 mac-
rophages treated with CpG-ODN or GpC-ODN (2 M), E. histolytica
DNA (30 g/ml), or LPS (1 g/ml) for 3 h. Data points represent
means  standard errors of the means of the results obtained from
three experiments.
FIG. 2. E. histolytica DNA induces TNF- protein production.
RAW 264.7 macrophages were treated in vitro for 24 h with media
only, LPS (1 g/ml), E. histolytica (E.h) DNA (30 g/ml), S. enterica
serovar Typhimurium (S.t) DNA (30 g/ml), calf thymus (C. thymus)
DNA (30 g/ml), or DNase-treated E. histolytica DNA (30 g/ml).
Culture supernatants were used in an L929 TNF- bioassay. Data
points represent means  standard errors of the means of the results
obtained from three experiments. An asterisk indicates a significant
increase in TNF- protein level compared to results seen with cells
treated with media only (P 	 0.05). The blot represents the corre-
sponding bands for TNF- protein (17 kDa) in culture supernatants.
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signaling and also demonstrated that the concentration of in-
hibitors used, which could have accounted for reduced mRNA
levels, did not cause cytotoxicity.
HEK-TLR9 NF-B reporter assay. We suspected that TLR9
might be involved in E. histolytica DNA macrophage activa-
tion, in which case NF-B would be involved in proinflamma-
tory cytokine production. HEK 293 cells were transiently trans-
fected with human TLR9 and an NF-B-luciferase reporter
plasmid and treated with various stimuli. The most effective
NF-B activator was CpG-ODN followed by S. enterica serovar
Typhimurium DNA and E. histolytica DNA (Fig. 5). In con-
trast, DNase-treated E. histolytica DNA had reduced NF-B
activity whereas calf thymus DNA did not significantly induce
any activation.
Impaired response to E. histolytica DNA in MYD88/ cells.
MYD88 is an adaptor protein in the signal transduction path-
way mediated by Toll receptors, and it is essential for mounting
an innate immune response. We propagated bone marrow-
derived macrophages from wild-type and MYD88/ mice to
assess the biological function of TLR signaling in response to
E. histolytica DNA. In wild-type macrophages both LPS and E.
histolytica DNA induced high TNF- mRNA expression levels
(Fig. 6A and B). In contrast, MYD88/ macrophages showed
significantly reduced TNF- expression in response to E. his-
tolytica DNA. LPS also had reduced potency in the MYD88/
FIG. 3. E. histolytica DNA activates macrophage iNOS production.
(A) Real-time PCR analysis was performed on IFN- (100 U/ml)-
primed RAW 264.7 macrophage mRNA collected after 6 h of in vitro
incubation with CpG-ODN (2 M), LPS (1 g/ml), E. histolytica (E.h)
DNA (30 g/ml), S. enterica serovar Typhimurium (S.t) DNA (30
g/ml), and calf thymus (C. thymus) DNA (30 g/ml). Data are rep-
resented as severalfold increases over medium-only control results for
mRNA expression. (B) Macrophages were stimulated as described
above for 24 h, and culture supernatants were used in a Griess reaction
to measure nitrite levels. Data points represent means  standard
errors of the means of the results obtained from three experiments. An
asterisk indicates a significant increase in nitrite level compared to the
results obtained with cells treated with media only (P 	 0.05).
FIG. 4. TNF- expression by E. histolytica DNA-stimulated macrophages requires endosomal acidification. RAW 264.7 macrophages were
pretreated for 30 min with or without chloroquine (5 g/ml) or monensin (20 M) and subsequently stimulated for 3 h with E. histolytica (E.h)
DNA (30 g/ml), S. enterica serovar Typhimurium (S.t) DNA (30 g/ml), or LPS (1 g/ml). mRNA was collected, and the level of TNF-
expression was measured by real-time PCR. Data points represent means  standard errors of the means of the results obtained from three
experiments. An asterisk indicates a significant decrease in level compared to the results obtained with cells not treated with inhibitors (P 	 0.05).
FIG. 5. TLR9-dependent NF-B activation by E. histolytica DNA.
HEK 293 cells were transiently transfected with pcDNA-human TLR9
(pcDNA-hTLR9) and NF-B luciferase reporter plasmid and treated
with CpG-ODN (2 M), S. enterica serovar Typhimurium (S.t) DNA (30
g/ml), E. histolytica (E.h) DNA (30 g/ml), DNAse-treated E. histolytica
DNA (30 g/ml), or calf thymus (C. thymus) DNA (30 g/ml). Luciferase
induction was measured and is reported as severalfold increases in level
compared to the results obtained with cells transfected with empty
pcDNA plasmid. Data points represent means  standard errors of the
means of the results obtained from three experiments.
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macrophages but to a lesser extent than E. histolytica DNA.
Thus, E. histolytica DNA-mediated signal transduction is de-
pendent on MYD88, a key adaptor protein in TLR9 signaling.
MAPK and NF-B activation by E. histolytica DNA. MYD88
is known to be involved in the activation of all three MAPK
pathways in TLR signaling. Therefore, we analyzed MAPK
activation in response to various stimuli known to require TLR
signaling. Cells were treated for 30 min, and cellular extracts were
probed in Western blot analyses using phosphorylated MAPK
antibodies. CpG-ODN, LPS, and S. enterica serovar Typhi-
murium DNA as well as E. histolytica DNA all induced phospho-
rylation of p38, ERK, and JNK whereas calf thymus DNA and
medium alone did not (Fig. 7). Next, we confirmed the activation
of NF-B by detecting p65 subunit translocation into the nucleus
by immunofluorescence. Treated and untreated cells were stained
with a p65 antibody and visualized for fluorescence. RAW mac-
rophages that were not treated or were treated with calf thymus
DNA showed p65 staining in the cytoplasm, indicating no NF-B
activation (Fig. 8a and b). However, macrophages treated with S.
enterica serovar Typhimurium DNA, LPS, or E. histolytica DNA
exhibited strong p65 staining in the nucleus indicative of p65
translocation and NF-B activation (Fig. 8c, d, and e). Thus, E.
histolytica DNA activates NF-B in a manner similar to that seen
with LPS and bacterial DNA.
Interplay between LPS and E. histolytica DNA. Desensitiza-
tion, or tolerance, can occur in vitro with submaximal doses of
LPS that reduce macrophage effector functions in response to
subsequent stimulation with other activators. Similarly, activa-
tion through MYD88-dependent pathways can prime cells to
respond to LPS in a MYD88-independent way (4). In the case
of amebiasis, not all patients develop invasive disease and the
factors involved in susceptibility are yet unknown. To consider
the possibility that E. histolytica DNA could alter immune
activation or deactivation, we examined the interplay with LPS.
We determined the submaximal doses of LPS and E. histolytica
DNA (data not shown) and used those concentrations to eval-
uate the interplay between LPS and E. histolytica DNA mac-
rophage activation. Submaximal doses of LPS and E. histolytica
DNA alone did not induce TNF- expression (Fig. 9A); nei-
ther did treatment with both submaximal doses simultaneously.
Pretreatment of cells with E. histolytica DNA, however, in-
creased the subsequent response to submaximal LPS stimula-
tion. On the other hand, treatment with LPS tolerized the
response to E. histolytica DNA, as this order of stimulation
induced less TNF- expression. In fact, Western blot analysis
FIG. 6. MYD88 is required for E. histolytica DNA-induced TNF-
expression. Bone marrow-derived macrophages were propagated from
wild-type and MYD88/ mice and stimulated in vitro for 3 h with
media, LPS (1 g/ml), or E. histolytica (E.h) DNA (30 g/ml). TNF-
mRNA expression was measured by real-time PCR (A), and PCR prod-
ucts were processed on 1.5% agarose gels (B). Data points represent
means  standard errors of the means of the results obtained from three
experiments. An asterisk indicates a significant decrease in TNF- expres-
sion compared to wild-type macrophage results (P 	 0.05).
FIG. 7. Macrophage activation by E. histolytica DNA is mediated by
MAPK. RAW 264.7 macrophages were stimulated for 30 min with me-
dium only (control), LPS (1 g/ml), E. histolytica (E.h) DNA (30 g/ml),
S. enterica serovar Typhimurium (S.t) DNA (30 g/ml), CpG-ODN (2
M), and calf thymus DNA (30 g/ml). Cellular extracts were separated
by electrophoresis and then blotted and probed with antibodies specific
for phosphorylated ERK, JNK, or p38. Total actin antibody was used as
a loading control. Data shown are from one experiment and are repre-
sentative of the results of three independent experiments.
FIG. 8. Immunofluorescence analysis of NF-B activation. RAW
264.7 cells were treated in vitro for 45 min with medium (a), calf
thymus DNA (b), S. enterica serovar Typhimurium DNA (c), LPS (d),
or E. histolytica DNA (e) and assessed for p65 subunit localization.
Isotype controls were stimulated with LPS and probed with normal
mouse immunoglobulin G (f). Images are representative of the results
of three independent experiments.
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demonstrated that submaximal LPS doses do not induce p38
phosphorylation, while pretreatment with E. histolytica DNA
could increase this phosphorylation event (Fig. 9B). We com-
pared the priming effects of submaximal E. histolytica DNA to
those of CpG-ODN and found that TNF- expression patterns
were similar with both treatments (Fig. 9C). In both cases,
pretreatment with CpG DNA (ODN or E. histolytica) in-
creased the response to LPS (P 	 0.05) whereas pretreatment
with LPS reduced the response to CpG DNA.
In vivo proinflammatory effect of E. histolytica DNA. Finally,
we addressed in vivo response to E. histolytica DNA in the
gerbil model of amebiasis. We evaluated the protective potential
of E. histolytica DNA in comparison to that of Gal-lectin, a known
parasite immunogen. Animals were immunized with 50 g E.
histolytica DNA or 10 g Gal-lectin or both E. histolytica DNA
and Gal-lectin. Upon challenge infection with live amebic tropho-
zoites, E. histolytica DNA alone and Gal-lectin alone demon-
strated equal levels of protective immunity against amebic liver
abscess formation (Table 1). Immunization with both E. histo-
lytica DNA and Gal-lectin, however, conferred complete protec-
tion. Spleen cells were isolated from immunized animals, and
cytokine expression was analyzed by real-time PCR. Figure 10
shows that both E. histolytica DNA and Gal-lectin induced the
expression of IL-4 and IFN- but that animals immunized with
both antigens had significantly higher levels of cytokine expres-
sion, specifically, of IFN- expression (P 	 0.05).
DISCUSSION
The mammalian immune system recognizes foreign DNA
through TLR9 expressed on immune cells. This recognition is
ascribed to unmethylated CpG motifs, which are present at a
FIG. 9. E. histolytica DNA pretreatment enhances subsequent activation of macrophages by submaximal LPS. (A) RAW 264.7 cells were left
untreated or pretreated for 6 h with submaximal LPS (0.1 ng/ml) or E. histolytica (E.h) DNA (1 g/ml). After pretreatment, cells were washed and
treated for 3 h with medium or with LPS or E. histolytica DNA or with both simultaneously (LPS/E.h) at the concentrations specified above. TNF-
mRNA expression was measured by real-time PCR. (B) Western blot analysis of p38 phosphorylation in cells treated with medium (–ve), LPS (0.1
ng/ml), or E. histolytica DNA (1 g/ml) or pretreated with E. histolytica DNA as described above and subsequently stimulated with LPS. (C) TNF-
mRNA expression in cells treated as described above or treated with CpG-ODN (2 M) instead of E. histolytica DNA. Data points represent
means  standard errors of the means of the results obtained from three experiments. An asterisk indicates a significant increase in TNF-
expression compared to the results seen with cells treated with submaximal doses alone (P 	 0.05).
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high frequency in DNA of bacteria and other pathogens. In the
event of an E. histolytica infection, the lysis of trophozoites may
allow the intestinal immune system to sample amebic DNA
and induce an inflammatory response. In this report we show
that E. histolytica DNA stimulates macrophage activation in a
TLR9-dependent manner similar to that seen with CpG DNA.
Our studies clearly demonstrate that E. histolytica DNA is a
stimulus for macrophage activation. As is consistent with the
activation potential of CpG DNA, E. histolytica DNA induced
TNF- expression in murine macrophages. This cytokine ex-
pression was blocked by the presence of chloroquine and mo-
nensin, indicating signaling via TLR9. Moreover, we found
that E. histolytica DNA could induce NF-B activation in
HEK-TLR9-transfected cells. TLR signaling was confirmed by
the requirement for the presence of MYD88 for E. histolytica
DNA activity. Taken together, these results demonstrate that
E. histolytica DNA can trigger innate immune responses.
Monocytes-macrophages, dendritic cells, and B cells recog-
nize unmethylated CpG dinucleotides through TLR9 (28). It is
well established that bacterial DNA is a potent immune stim-
ulator due to the high frequency of these unmethylated CpG
motifs. In contrast to bacterial DNA, E. histolytica DNA has an
AT-rich (75.3%) genome and CG dinucleotides are underrep-
resented (22). It has been reported that E. histolytica has a
DNA methyltransferase of the DNMT2 family which targets
rRNA (29). Methylation seems to occur mostly at AT dinucle-
otides and not at the common CpG site as in vertebrate sys-
tems (5). It is interesting that despite the differences between
bacteria and this parasite in DNA composition characteristics,
E. histolytica DNA was still able to induce some activation in
macrophages. However, the variation in the magnitude of re-
sponses could be attributed to these innate differences in DNA
composition, mainly, the degree of difference in CpG frequency
methylation patterns. The observation that S. enterica serovar
Typhimurium DNA and CpG-ODN had greater activation po-
tential than E. histolytica DNA was consistent with this theory.
Other protozoan parasite DNAs such as that of Trypanosoma
brucei have also been reported to activate immune cells; however,
the extent of activation is lower than that seen with bacterial DNA
due to differential unmethylated CpG frequencies (11).
Prominent inflammation is a major component of amebiasis,
and NF-B activation is known to be required for initiation of
this response in cases of amebic infection (38). NF-B controls
the gene expression of proinflammatory cytokines such as IL-1,
IL-6, and TNF-. Here we report that E. histolytica DNA can
activate NF-B via TLR9 signaling and can induce the produc-
tion of the proinflammatory cytokine TNF- as well as nitric
oxide in macrophages. It has been shown that activation of
macrophages with Th1 cytokines results in amebicial activity
mediated by nitric oxide production and that this activation
may be essential for innate immunity against the parasite (35,
36, 39). Since macrophages have an important role in disease
protection, it was important to identify a parasite molecule that
was able to stimulate a cell-mediated response. As is consistent
with the crucial role of cellular responses, our immunization
studies demonstrated resistance to amebic infection mediated
by IFN- production. In humans, higher IFN- production has
been correlated with a reduced risk of amebic disease (12).
IFN- is a key Th1 cytokine which could prime macrophages at
the site of infection to respond to amebic DNA and become
cytotoxic against the invading parasite. Previous studies have
demonstrated that repeated administration of CpG-ODN in
mice could protect against lethal bacterial or parasite challenge
infections and that this protection is associated with high-level
IL-6 and IFN- production (15, 23). In this way, E. histolytica
DNA injections could have elicited immune activation suffi-
cient to provide some protection against parasite challenge
infections. However, combining E. histolytica DNA with an-
other strong Th1 immunogen, Gal-lectin, conferred complete
protection mediated by higher Th1 responses.
The majority of cases of E. histolytica infection do not result
in invasive disease; however, the nature of the initiation of the
invasion process remains unknown. Evidence suggests that
modulation of host response may result in the establishment
and persistence of amebic infection. It is possible that amebic
colitis may be a result of immune responses to direct parasite
insult, but it could also be due to a combination of gut immune
events that could facilitate invasion. It has been increasingly
observed that different TLR agonists can have an impact on
the immune response to other TLR ligands, resulting in altered
inflammatory responses (7, 8). During infection, the immune
system is exposed to various stimuli, and the interplay between
them could potentiate disease or attenuate it. In this study we
evaluated the priming and tolerance effects of LPS and E.
histolytica DNA. LPS is recognized by TLR4, which can signal
FIG. 10. Taqman real-time PCR analysis of spleen cytokine gene
expression. Gene expression levels were normalized to 18S rRNA and
are represented as severalfold increases over the results seen with
normal nontreated gerbil mRNA. There were higher levels of IFN-
and IL-4 in the protected gerbils (*, P 	 0.05). Data points represent
means  standard errors of the means of results from three indepen-
dent PCRs. Eh, E. histolytica.
TABLE 1. Prevention of ALA in gerbils by immunization with
E. histolytica DNA




PBS 12  4  0
E. histolytica DNA 26  5  33




a ALA contents were aspirated, and viable trophozoite levels were determined
by in vitro culture. , presence; , absence.
b Treatment efficacy to protect against ALA  100  (protected gerbil results/
infected gerbil results); n  6/group.
c P 	 0.05.
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via MYD88-dependent and MYD88-independent pathways
(4), while CpG DNA can only signal in a MYD88-dependent
manner (24). Our results demonstrated that E. histolytica DNA
could prime macrophages to be responsive to otherwise non-
stimulating LPS doses. On the other hand, LPS rendered macro-
phages less responsive to E. histolytica DNA, causing a tolerance
effect. This effect could be due to the MYD88 pathways involved
in TLR4 signaling, whereby pretreatment with LPS would down-
regulate the potential to subsequently signal through TLR9, as
MYD88 would have been activated. The reverse addition of E.
histolytica DNA followed by LPS, however, allows subsequent
stimulation with LPS to signal through an alternative MYD88-
independent pathway. The nature of host susceptibility to amebic
infection is unknown; however, one could postulate that previous,
concurrent, and subsequent intestinal infections with other patho-
gens could alter the outcome of amebic infection.
In conclusion, the results reported herein indicate that E.
histolytica DNA could represent a PAMP that is recognized by
the innate immune system through TLR9. This finding further
elucidates the initial proinflammatory host response to amebic
infection and identifies another parasite molecule involved in
the multifactorial process of amebiasis. Future studies will
need to evaluate the activation potential of E. histolytica DNA
with other cell types and identify its role in pathogenesis and or
protection from disease.
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